share_log

Presidio Property Trust, Inc. Announces Earnings for the First Quarter Ended March 31, 2024

Presidio Property Trust, Inc. Announces Earnings for the First Quarter Ended March 31, 2024

普雷西迪奧房地產信託公司公佈截至2024年3月31日的第一季度收益
Accesswire ·  05/15 04:30

SAN DIEGO, CA / ACCESSWIRE / May 14, 2024 / Presidio Property Trust, Inc. (NASDAQ:SQFT)(NASDAQ:SQFTP)(NASDAQ:SQFTW) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today reported earnings for its quarter ended March 31, 2024.

加利福尼亞州聖地亞哥/ACCESSWIRE/2024年5月14日/內部管理的多元化房地產投資信託基金(“房地產投資信託基金”)普雷西迪奧房地產信託公司(納斯達克股票代碼:SQFTW)(“公司”)今天公佈了截至2024年3月31日的季度收益。

"During the first quarter of 2024, we have signed leasing transactions totaling 24,476 sf, including new leases and renewals. We believe 2024 is off to a good start. With currently scheduled lease expirations during 2024 at a level nearly one-half of that during 2023, there is good reason to anticipate that our rent roll will be more stable through the end of the year, even considering this period of uncertainty in the commercial real estate markets, " said Gary Katz, the Company's Chief Investment Officer

“在2024年第一季度,我們簽署了總面積爲24,476平方英尺的租賃交易,包括新的租賃和續約。我們相信2024年有了一個良好的開端。該公司首席投資官加里·卡茨說,目前計劃在2024年到期的租約到期時間幾乎是2023年的一半,因此即使考慮到商業房地產市場這段不確定時期,我們也有充分的理由預計,到年底,我們的租金將更加穩定

Three Months Ended March 31, 2024, Financial Results

截至2024年3月31日的三個月,財務業績

Net loss attributable to the Company's common stockholders for the three months ended March 31, 2024 was approximately $5.8 million, or ($0.47) per basic and diluted share, compared to a net loss of approximately $1.5 million, or $(0.13) per basic and diluted share for the three months ended March 31, 2023. The change in net income attributable to the Company's common stockholders was a result of:

截至2024年3月31日的三個月,歸屬於公司普通股股東的淨虧損約爲580萬美元,合每股基本和攤薄後虧損0.47美元,而截至2023年3月31日的三個月,淨虧損約爲150萬美元,合每股基本和攤薄後每股虧損0.13美元。歸屬於公司普通股股東的淨收益的變化是由於:

Total revenues were approximately $4.8 million for the three months ended March 31, 2024, compared to approximately $4.1 million for the same period in 2023. As of March 31, 2024, we had approximately $135.3 million in net real estate assets including 88 model homes, compared to approximately $133.9 million in net real estate assets including 98 model homes at March 31, 2023. The average number of model homes held during the three months ended March 31, 2024 and 2023 was 99 and 95, respectively. The change in revenue is directly related to the average real estate assets held during the period, new commercial real estate leases, and model home transaction fees earned by the Company during the current period.

During the three months ended March 31, 2024, we recognized a non-cash impairment charge of approximately $0.1 million related to four model homes, three of which already had an impairment as of December 31, 2023. The new impairment charges for the four model homes reflects the estimated sales prices for these specific model homes in April and May 2024. These homes had an abnormally short hold period, less than two years, where the builder changed their product style in the neighborhoods where our model homes are located, in Texas, after we had purchased the homes. We do not believe these losses are indicative of our overall model home portfolio.

Model home transactions fees were up $95k in Q1 2024 as compared to Q1 2023 related to the number of model home sales during the first quarter of 2024. There were 27 model home sales in 2024, compared to three during the first quarter in 2023. In connection with those sales, we recorded a gain of $2.0 million and $0.4 million during Q1 2024 and Q1 2023, respectively.

Our investments in the common stock and warrants of Conduit Pharmaceuticals Inc. presented in the consolidated balance sheets were measured at fair value using Level 1 market prices, taking into account the adoption of ASU 2022-03 Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, and totaled approximately $14.5 million and $18.3 million as of March 31, 2024 and December 31, 2023, respectively, with a cost basis of approximately $7.5 million. For the three months ended March 31, 2024, the fair value remeasure resulted in a loss on marketable securities totaling approximately $3.9 million. As of March 31, 2024, our investments in in these securities presented in the consolidated balance sheets were measured at fair value using Level 1 market prices, which closed at $3.59 per share and $0.06 per warrant.

截至2024年3月31日的三個月,總收入約爲480萬美元,而2023年同期約爲410萬美元。截至2024年3月31日,我們的房地產淨資產約爲1.353億美元,包括88套樣板房,而截至2023年3月31日,包括98套樣板房的房地產淨資產約爲1.339億美元。在截至2024年3月31日和2023年3月31日的三個月中,平均持有的樣板房數量分別爲99套和95套。收入的變化與該期間持有的平均房地產資產、新的商業房地產租賃以及公司在本期獲得的樣板房交易費用直接相關。

在截至2024年3月31日的三個月中,我們確認了與四套樣板房相關的約10萬美元的非現金減值費用,其中三套截至2023年12月31日已出現減值。四套樣板房的新減值費用反映了這些特定樣板房在2024年4月和5月的估計銷售價格。這些房屋的保質期異常短,不到兩年,在我們購買房屋後,建築商改變了德克薩斯州樣板房所在社區的產品風格。我們認爲這些損失並不代表我們的整體樣板房投資組合。

與2023年第一季度相比,2024年第一季度的樣板房交易費用增加了9.5萬美元,這與2024年第一季度的樣板房銷售數量有關。2024年的樣板房銷售量爲27套,而2023年第一季度爲3套。在這些銷售方面,我們在2024年第一季度和2023年第一季度分別錄得200萬美元和40萬美元的收益。

我們對合並資產負債表中列報的Conduit Pharmicals Inc.普通股和認股權證的投資採用了亞利桑那州立大學2022-03年受合同銷售限制的股票證券的公允價值計量,截至2024年3月31日和2023年12月31日,總額分別約爲1,450萬美元和1,830萬美元,成本基礎約爲750萬美元。在截至2024年3月31日的三個月中,公允價值調整措施導致有價證券虧損總額約390萬美元。截至2024年3月31日,我們對合並資產負債表中列報的這些證券的投資以公允價值計量,第一級市場價格收於每股3.59美元,每份認股權證0.06美元。

FFO (non-GAAP) decreased by approximately $0.7 million to approximately $(971,367) from $(228,914) for the three months ended March 31, 2024 and 2023, respectively. A reconciliation of FFO to net income, the most directly comparable GAAP financial measure, is attached to this press release. However, because FFO excludes depreciation and amortization as well as the changes in the value of the Company's properties that result from use or market conditions, each of which have real economic effects and could materially impact the Company's results from operations, the utility of FFO as a measure of the Company's performance is limited.

截至2024年3月31日和2023年3月31日的三個月,FFO(非公認會計准則)分別從228,914美元(228,914美元)減少了約70萬美元至約971,367美元。本新聞稿附有FFO與淨收入的對賬,這是最直接可比的GAAP財務指標。但是,由於FFO不包括折舊和攤銷以及因使用或市場條件而導致的公司房產價值的變化,每種變化都具有實際經濟影響,並可能對公司的經營業績產生重大影響,因此FFO作爲衡量公司業績的效用是有限的。

We believe Core FFO (non-GAAP) provides a useful metric in comparing operations between reporting periods and in assessing the sustainability of our ongoing operating performance. Core FFO decreased by about $0.4 million, from approximately $31,932 for the three months ended March 31, 2023, to approximately $(429,445) for the three months ended March 31, 2024. A reconciliation of Core FFO to net income, the most directly comparable GAAP financial measure, is attached to this press release.

我們認爲,Core FFO(非公認會計准則)爲比較報告期之間的運營和評估我們持續經營業績的可持續性提供了有用的指標。核心FFO減少了約40萬美元,從截至2023年3月31日的三個月的約31,932美元下降到截至2024年3月31日的三個月的約429,445美元。本新聞稿附有核心FFO與淨收入的對賬情況,這是最直接可比的GAAP財務指標。

Acquisitions and Dispositions for the three months ended March 31, 2024:

截至2024年3月31日的三個月的收購和處置:

  • The Company acquired five model homes for approximately $2.2 million. The purchase price was paid through cash payments of approximately $0.6 million and mortgage notes of approximately $1.6 million.
  • The Company sold 27 model homes for approximately $14.0 million and recognized a gain of approximately $2.0 million.
  • 該公司以約220萬美元的價格收購了五套樣板房。收購價款通過約60萬美元的現金支付和約160萬美元的抵押貸款票據支付。
  • 該公司以約1400萬美元的價格出售了27套樣板房,並確認了約200萬美元的收益。

Dividends paid during the three months ended March 31, 2024:

在截至2024年3月31日的三個月中支付的股息:

The following is a summary of distributions declared per share of our Series A Common Stock and for our Series D Preferred Stock for the three months ended March 31, 2024 and 2023.

以下是截至2024年3月31日和2023年3月31日的三個月中我們的A系列普通股和D系列優先股的每股申報分配摘要。

Series A Common Stock

A 系列普通股

Quarter Ended
2024 2023
Distributions Declared Distributions Declared
March 31
$ - $ 0.022
Total
$ - $ 0.022
季度結束
2024 2023
已宣佈的發行版 已宣佈的發行版
3 月 31 日
$ - $ 0.022
總計
$ - $ 0.022

Series D Preferred Stock

D 系列優先股

Month
2024 2023
Distributions Declared Distributions Declared
January
$ 0.19531 $ 0.19531
February
0.19531 0.19531
March
0.19531 0.19531
Total
$ 0.58593 $ 0.58593
2024 2023
已宣佈的發行版 已宣佈的發行版
一月
$ 0.19531 $ 0.19531
二月
0.19531 0.19531
三月
0.19531 0.19531
總計
$ 0.58593 $ 0.58593

About Presidio Property Trust

普雷西迪奧財產信託基金簡介

Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development. For more information on Presidio, please visit the Company's website at

Presidio是一家內部管理的多元化房地產投資信託基金,持有樣板房產,這些房產以三重淨租給房屋建築商、辦公、工業和零售物業。普雷西迪奧的樣板房出租給位於亞利桑那州、伊利諾伊州、德克薩斯州、威斯康星州和佛羅里達州的房屋建築商。我們的辦公、工業和零售物業主要位於科羅拉多州,物業也位於馬里蘭州、北達科他州、德克薩斯州和南加州。儘管房地產的地理集群使我們能夠通過規模經濟降低運營成本,用較少的人員爲幾處房產提供服務,但它使我們容易受到這些分散地理區域不斷變化的市場條件的影響,包括因 COVID-19 而發展的地理區域。普雷西迪奧擁有Conduit Pharmicals Inc. 已發行普通股約6.5%的股份。Conduit Pharmicals Inc. 是一家與疾病無關的多資產臨床階段與疾病無關的生命科學公司,爲化合物開發提供了有效的模型。有關 Presidio 的更多信息,請訪問該公司的網站

Definitions

定義

Non-GAAP Financial Measures

非公認會計准則財務指標

Funds from Operations ("FFO") - The Company evaluates performance based on Funds From Operations, which we refer to as FFO, as management believes that FFO represents the most accurate measure of activity and is the basis for distributions paid to equity holders. The Company defines FFO as net income or loss (computed in accordance with GAAP), excluding gains (or losses) from sales of property, hedge ineffectiveness, acquisition costs of newly acquired properties that are not capitalized and lease acquisition costs that are not capitalized plus depreciation and amortization, including amortization of acquired above and below market lease intangibles and impairment charges on properties or investments in non-consolidated REITs, and after adjustments to exclude equity in income or losses from, and, to include the proportionate share of FFO from, non-consolidated REITs.

運營資金(“FFO”)——公司根據運營資金(我們稱之爲FFO)評估業績,因爲管理層認爲FFO是最準確的活動衡量標準,也是向股東支付的分配的基礎。公司將FFO定義爲淨收益或虧損(根據公認會計原則計算),不包括房地產銷售的收益(或虧損)、對沖無效、新收購的未資本化房產的收購成本和未資本化的租賃收購成本加上折舊和攤銷,包括收購的高於和低於市場的租賃無形資產的攤銷和房地產或非合併房地產投資信託基金投資的減值費用,以及調整後不包括收益權益或來自和的損失,包括來自非合併房地產投資信託基金的FFO的比例份額。

However, because FFO excludes depreciation and amortization as well as the changes in the value of the Company's properties that result from use or market conditions, each of which have real economic effects and could materially impact the Company's results from operations, the utility of FFO as a measure of the Company's performance is limited. In addition, other REITs may not calculate FFO in accordance with the NAREIT definition as the Company does, and, accordingly, the Company's FFO may not be comparable to other REITs' FFO. Accordingly, FFO should be considered only as a supplement to net income as a measure of the Company's performance.

但是,由於FFO不包括折舊和攤銷以及因使用或市場條件而導致的公司房產價值的變化,每種變化都具有實際經濟影響,並可能對公司的經營業績產生重大影響,因此FFO作爲衡量公司業績的效用是有限的。此外,其他房地產投資信託基金可能無法像公司那樣根據NAREIT的定義計算FFO,因此,該公司的FFO可能無法與其他房地產投資信託基金的FFO相提並論。因此,FFO應僅被視爲衡量公司業績的淨收入的補充。

Core Funds from Operations ("Core FFO") - We calculate Core FFO by using FFO as defined by NAREIT and adjusting for certain other non-core items. We exclude from our Core FFO calculation acquisition costs, loss on early extinguishment of debt, changes in the fair value of the earn-out, changes in fair value of contingent consideration, non-cash warrant dividends and the amortization of stock-based compensation.

來自運營的核心資金(“核心FFO”)-我們使用NAREIT定義的FFO並根據某些其他非核心項目進行調整來計算核心FFO。我們在覈心FFO計算中不包括收購成本、提前清償債務造成的損失、收益公允價值的變化、或有對價公允價值的變化、非現金認股權證分紅和股票薪酬的攤銷。

We believe Core FFO provides a useful metric in comparing operations between reporting periods and in assessing the sustainability of our ongoing operating performance. Other equity REITs may calculate Core FFO differently or not at all, and, accordingly, the Company's Core FFO may not be comparable to such other REITs' Core FFO.

我們認爲,Core FFO爲比較報告期之間的運營以及評估我們持續經營業績的可持續性提供了有用的指標。其他股票房地產投資信託基金對核心FFO的計算方式可能有所不同或根本不一樣,因此,該公司的核心FFO可能無法與其他房地產投資信託基金的核心FFO相提並論。

Cautionary Note Regarding Forward-Looking Statements

關於前瞻性陳述的警示說明

This press release contains statements that are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and other federal securities laws. Forward-looking statements are statements that are not historical, including statements regarding management's intentions, beliefs, expectations, representations, plans or predictions of the future, and are typically identified by such words as "believe," "expect," "anticipate," "intend," "estimate," "may," "will," "should" and "could." Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements also include statements relating to the closing of the business combination with Conduit within a certain timeframe or at all. These forward-looking statements are based upon the Company's present expectations, but these statements are not guaranteed to occur. Except as required by law, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes. Investors should not place undue reliance upon forward-looking statements. For further discussion of the factors that could affect outcomes, please refer to the "Risk Factors" section of the Company's documents filed with the SEC, copies of which are available on the SEC's website, www.sec.gov.

本新聞稿包含1995年《私人證券訴訟改革法》、經修訂的1933年《證券法》第27A條、經修訂的1934年《證券交易法》第21E條以及其他聯邦證券法所指的 “前瞻性陳述”。前瞻性陳述是非歷史陳述,包括有關管理層意圖、信念、預期、陳述、計劃或未來預測的陳述,通常用 “相信”、“期望”、“預期”、“打算”、“估計”、“可能”、“將”、“應該” 和 “可能” 等詞語來識別。由於此類陳述包括風險、不確定性和意外情況,因此實際結果可能與此類前瞻性陳述所表達或暗示的結果存在重大差異。前瞻性陳述還包括與在一定時間範圍內或完全關閉與Conduit的業務合併有關的陳述。這些前瞻性陳述基於公司目前的預期,但不能保證這些陳述會發生。除非法律要求,否則公司沒有義務公開更新或修改任何前瞻性陳述以反映基本假設或因素、新信息、數據或方法、未來事件或其他變化的變化。投資者不應過分依賴前瞻性陳述。有關可能影響結果的因素的進一步討論,請參閱公司向美國證券交易委員會提交的文件的 “風險因素” 部分,這些文件的副本可在美國證券交易委員會的網站www.sec.gov上查閱。

Investor Relations Contact:

投資者關係聯繫人:

Presidio Property Trust, Inc.
Lowell Hartkorn, Investor Relations
LHartkorn@presidiopt.com
Telephone: (760) 471-8536 x1244

普雷西迪奧房地產信託公司
洛厄爾·哈特科恩,投資者關係
LHartkorn@presidiopt.com
電話:(760) 471-8536 x1244

Presidio Property Trust, Inc. and Subsidiaries
Consolidated Balance Sheets

普雷西迪奧房地產信託公司及其子公司
合併資產負債表

March 31, December 31,
2024 2023
(Unaudited)
ASSETS
Real estate assets and lease intangibles:
Land
$ 19,716,839 $ 21,660,644
Buildings and improvements
126,800,920 133,829,416
Tenant improvements
18,695,226 17,820,948
Lease intangibles
3,776,654 4,110,139
Real estate assets and lease intangibles held for investment, cost
168,989,639 177,421,147
Accumulated depreciation and amortization
(38,983,073) (38,725,356)
Real estate assets and lease intangibles held for investment, net
130,006,566 138,695,791
Real estate assets held for sale, net
5,254,952 5,459,993
Real estate assets, net
135,261,518 144,155,784
Other assets:
Cash, cash equivalents and restricted cash
7,159,432 6,510,428
Deferred leasing costs, net
1,563,551 1,657,055
Goodwill
1,574,000 1,574,000
Investment in Conduit Pharmaceuticals marketable securities (see Notes 2 & 9)
14,457,288 18,318,521
Deferred tax asset
346,762 346,762
Other assets, net (see Note 6)
3,115,782 3,400,088
Total other assets
28,216,815 31,806,854
TOTAL ASSETS
$ 163,478,333 $ 175,962,638
LIABILITIES AND EQUITY
Liabilities:
Mortgage notes payable, net
$ 98,599,984 $ 103,685,444
Mortgage notes payable related to properties held for sale, net
3,692,713 4,027,829
Mortgage notes payable, total net
102,292,697 107,713,273
Accounts payable and accrued liabilities
4,076,683 4,792,034
Accrued real estate taxes
1,252,289 1,953,087
Dividends payable
174,011 174,011
Lease liability, net
8,090 16,086
Below-market leases, net
12,022 13,266
Total liabilities
107,815,792 114,661,757
Equity:
Series D Preferred Stock, $0.01 par value per share; 1,000,000 shares authorized; 890,946 shares issued and outstanding (liquidation preference $25.00 per share) as of March 31, 2024 and 890,946 shares issued and outstanding as of December 31, 2023
8,909 8,909
Series A Common Stock, $0.01 par value per share, shares authorized: 100,000,000; 12,429,139 shares and 12,265,061 shares were issued and outstanding at March 31, 2024 and December 31, 2023, respectively
124,291 122,651
Additional paid-in capital
182,533,423 182,310,219
Dividends and accumulated losses
(137,272,480) (131,508,785)
Total stockholders' equity before noncontrolling interest
45,394,143 50,932,994
Noncontrolling interest
10,268,398 10,367,887
Total equity
55,662,541 61,300,881
TOTAL LIABILITIES AND EQUITY
$ 163,478,333 $ 175,962,638
3月31日 十二月三十一日
2024 2023
(未經審計)
資產
房地產資產和租賃無形資產:
土地
$ 19,716,839 $ 21,660,644
建築物和裝修
126,800,920 133,829,416
租戶改進
18,695,226 17,820,948
租賃無形資產
3,776,654 4,110,139
爲投資、成本而持有的房地產資產和租賃無形資產
168,989,639 177,421,147
累計折舊和攤銷
(38,983,073) (38,725,356)
持有用於投資的房地產資產和租賃無形資產,淨額
130,006,566 138,695,791
待售房地產資產,淨額
5,254,952 5,459,993
房地產資產,淨額
135,261,518 144,155,784
其他資產:
現金、現金等價物和限制性現金
7,159,432 6,510,428
遞延租賃成本,淨額
1,563,551 1,657,055
善意
1,574,000 1,574,000
投資Conduit Pharmicals有價證券(見附註2和9)
14,457,288 18,318,521
遞延所得稅資產
346,762 346,762
其他資產,淨額(見附註6)
3,115,782 3,400,088
其他資產總額
28,216,815 31,806,854
總資產
$ 163,478,333 $ 175,962,638
負債和權益
負債:
應付抵押貸款票據,淨額
$ 98,599,984 $ 103,685,444
與待售房產相關的應付抵押貸款票據,淨額
3,692,713 4,027,829
應付抵押貸款票據,總額淨額
102,292,697 107,713,273
應付賬款和應計負債
4,076,683 4,792,034
應計房地產稅
1,252,289 1,953,087
應付股息
174,011 174,011
租賃負債,淨額
8,090 16,086
低於市場的租約,淨額
12,022 13,266
負債總額
107,815,792 114,661,757
股權:
D 系列優先股,每股面值0.01美元;授權1,000,000股;截至2024年3月31日已發行和流通890,946股股票(清算優先權每股25.00美元),截至2023年12月31日已發行和流通的890,946股股票
8,909 8,909
A系列普通股,每股面值0.01美元,授權股數:1億股;截至2024年3月31日和2023年12月31日,已分別發行和流通12,429,139股和12,265,061股
124,291 122,651
額外的實收資本
182,533,423 182,310,219
股息和累計虧損
(137,272,480) (131,508,785)
扣除非控股權益前的股東權益總額
45,394,143 50,932,994
非控股權益
10,268,398 10,367,887
權益總額
55,662,541 61,300,881
負債和權益總額
$ 163,478,333 $ 175,962,638

Presidio Property Trust, Inc. and Subsidiaries
Consolidated Statements of Operations

普雷西迪奧房地產信託公司及其子公司
合併運營報表

For the Three Months Ended March 31,
2024 2023
Revenues:
Rental income
$ 4,419,106 $ 3,942,053
Fees and other income
370,955 179,438
Total revenue
4,790,061 4,121,491
Costs and expenses:
Rental operating costs
1,563,577 1,574,990
General and administrative
2,084,450 1,964,620
Depreciation and amortization
1,351,018 1,333,574
Impairment of real estate assets
95,548 -
Total costs and expenses
5,094,593 4,873,184
Other income (expense):
Interest expense - mortgage notes
(1,515,206) (867,767)
Interest and other income, net
4,646 742,117
Gain on sales of real estate, net
2,018,095 417,337
Loss on Conduit Pharmaceuticals marketable securities (see footnote 9)
(3,861,233) -
Income expense
(79,565) (148,453)
Total other (expense) income, net
(3,433,263) 143,234
Net loss
(3,737,795) (608,459)
Less: Income attributable to noncontrolling interests
(1,503,868) (387,081)
Net loss attributable to Presidio Property Trust, Inc. stockholders
$ (5,241,663) $ (995,540)
Less: Preferred Stock Series D dividends
(522,032) (535,448)
Net loss attributable to Presidio Property Trust, Inc. common stockholders
$ (5,763,695) $ (1,530,988)
Net loss per share attributable to Presidio Property Trust, Inc. common stockholders:
Basic & Diluted
$ (0.47) $ (0.13)
Weighted average number of common shares outstanding - basic & dilutive
12,293,190 11,834,656
在截至3月31日的三個月中,
2024 2023
收入:
租金收入
$ 4,419,106 $ 3,942,053
費用和其他收入
370,955 179,438
總收入
4,790,061 4,121,491
成本和支出:
租金運營成本
1,563,577 1,574,990
一般和行政
2,084,450 1,964,620
折舊和攤銷
1,351,018 1,333,574
房地產資產減值
95,548 -
成本和支出總額
5,094,593 4,873,184
其他收入(支出):
利息支出——抵押貸款票據
(1,515,206) (867,767)
利息和其他收入,淨額
4,646 742,117
房地產銷售收益,淨額
2,018,095 417,337
Conduit Pharmicals有價證券的損失(見腳註9)
(3,861,233) -
收入支出
(79,565) (148,453)
其他(支出)收入總額,淨額
(3,433,263) 143,234
淨虧損
(3,737,795) (608,459)
減去:歸屬於非控股權益的收益
(1,503,868) (387,081)
歸屬於普雷西迪奧房地產信託公司股東的淨虧損
$ (5,241,663) $ (995,540)
減去:優先股D系列股息
(522,032) (535,448)
歸屬於普雷西迪奧房地產信託公司普通股股東的淨虧損
$ (5,763,695) $ (1,530,988)
歸屬於普雷西迪奧房地產信託公司普通股股東的每股淨虧損:
基礎版和稀釋版
$ (0.47) $ (0.13)
已發行普通股的加權平均數——基本股和攤薄股
12,293,190 11,834,656

FFO AND CORE FFO RECONCILIATION

FFO 和核心 FFO 對賬

For the Three Months Ended March 31,
2024 2023
Net loss attributable to Presidio Property Trust, Inc. common stockholders
$ (5,763,695) $ (1,530,988)
Adjustments:
Income attributable to noncontrolling interests
1,503,868 387,081
Depreciation and amortization
1,351,018 1,333,574
Amortization of above and below market leases, net
(1,244) (1,244)
Impairment of real estate assets
95,548 -
Loss on Conduit Pharma marketable securities
3,861,233 -
Loss (Gain) on sale of real estate assets
(2,018,095) (417,337)
FFO
$ (971,367) $ (228,914)
Stock Based Compensation
541,921 260,845
Core FFO
$ (429,445) $ 31,932
Weighted average number of common shares outstanding - basic
12,293,190 11,834,656
Core FFO / Wgt Avg Share
$ (0.035) $ 0.003
在截至3月31日的三個月中,
2024 2023
歸屬於普雷西迪奧房地產信託公司普通股股東的淨虧損
$ (5,763,695) $ (1,530,988)
調整:
歸屬於非控股權益的收益
1,503,868 387,081
折舊和攤銷
1,351,018 1,333,574
市場以上和以下租賃的攤銷,淨額
(1,244) (1,244)
房地產資產減值
95,548 -
Conduit Pharma有價證券的虧損
3,861,233 -
出售房地產資產的虧損(收益)
(2,018,095) (417,337)
FFO
$ (971,367) $ (228,914)
基於股票的薪酬
541,921 260,845
核心 FFO
$ (429,445) $ 31,932
已發行普通股的加權平均數量——基本
12,293,190 11,834,656
核心 FFO/Wgt 平均份額
$ (0.035) $ 0.003

SOURCE: Presidio Property Trust

來源:普雷西迪奧房地產信託基金


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論